Lingnan Modern Clinics In Surgery ›› 2021, Vol. 21 ›› Issue (04): 489-494.DOI: 10.3969/j.issn.1009-976X.2021.04.024
• Review • Previous Articles
GAO Si-min, HE Hai-yan
Contact:
HE Hai-yan, hehaiyan1125@163.com
高思敏, 何海艳*
通讯作者:
*何海艳:Email:hehaiyan1125@163.com
CLC Number:
GAO Si-min, HE Hai-yan. Impacts of the oncological treatment in the sexual health of women with breast cancer[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 489-494.
高思敏, 何海艳. 乳腺癌治疗过程对女性性健康影响的研究进展[J]. 岭南现代临床外科, 2021, 21(04): 489-494.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lingnanwaike.com/EN/10.3969/j.issn.1009-976X.2021.04.024
| [1] Laumann EO, Paik A, Rosen RC.Sexual dysfunction in the United States: prevalence and predictors[J]. JAMA, 1999, 281(6): 537-544. [2] Ganz P A.Sexual functioning after breast cancer: a conceptual framework for future studies[J]. Ann Oncol, 1997, 8(2): 105-107. [3] Dai Y, Cook OY, Yeganeh L, et al.Patient-Reported Barriers and Facilitators to Seeking and Accessing Support in Gynecologic and Breast Cancer Survivors With Sexual Problems: A Systematic Review of Qualitative and Quantitative Studies[J]. J Sex Med, 2020, 17(7): 1326-1358. [4] Wang LY, Pierdomenico A, Lefkowitz A, et al.Female Sexual Health Training for Oncology Providers: New Applications[J]. Sex Med, 2015, 3(3): 189-197. [5] Seguin L, Touzani R, Bouhnik AD, et al.Deterioration of Sexual Health in Cancer Survivors Five Years after Diagnosis: Data from the French National Prospective VICAN Survey[J]. Cancers (Basel), 2020, 12(11):3453. [6] Kim HW, Kim YH, Kang SY, et al.Gender Differences in Sexual Information Needs and Relating Factors in Cancer Patients: A Cross-Sectional Survey[J]. Int J Environ Res Public Health, 2021, 18(7):3752. [7] Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1):7-33. [8] Ussher JM, Perz J, Gilbert E.Information needs associated with changes to sexual well-being after breast cancer[J]. J Adv Nurs, 2013, 69(2): 327-337. [9] Cardoso F, Loibl S, Pagani O, et al.The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer[J]. Eur J Cancer, 2012, 48(18): 3355-3377. [10] Ganz PA, Desmond KA, Leedham B, et al.Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study[J]. J Natl Cancer Inst, 2002, 94(1): 39-49. [11] Lam WW, Ye M, Fielding R.Trajectories of quality of life among Chinese patients diagnosed with nasopharynegeal cancer[J]. PLoS One, 2012, 7(9): e44022. [12] Odo R, Potter C.Understanding the needs of young adult cancer survivors: a clinical perspective[J]. Oncology (Williston Park), 2009, 23(11 Suppl Nurse Ed): 23-27, 33. [13] Schover L R.Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility[J]. J Clin Oncol, 2008, 26(5): 753-758. [14] Panjari M, Bell RJ, Davis SR.Sexual function after breast cancer[J]. J Sex Med, 2011, 8(1): 294-302. [15] Shifren JL, Monz BU, Russo PA, et al.Sexual problems and distress in United States women: prevalence and correlates[J]. Obstet Gynecol, 2008, 112(5): 970-978. [16] Harlow BL, Stewart EG.A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia?[J]. J Am Med Womens Assoc (1972), 2003, 58(2): 82-88. [17] Pitts MK, Ferris JA, Smith AM, et al.Prevalence and correlates of three types of pelvic pain in a nationally representative sample of Australian women[J]. Med J Aust, 2008, 189(3): 138-143. [18] Mock V.Body image in women treated for breast cancer[J]. Nurs Res, 1993, 42(3): 153-157. [19] Paterson CL, Lengacher CA, Donovan KA, et al.Body Image in Younger Breast Cancer Survivors: A Systematic Review[J]. Cancer Nurs, 2016, 39(1): E39-58. [20] Aerts L, Christiaens MR, Enzlin P, et al.Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study[J]. Breast, 2014, 23(5): 629-636. [21] Engel J, Kerr J, Schlesinger-Raab A, et al.Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study[J]. Breast J, 2004, 10(3): 223-231. [22] Atisha D, Alderman AK, Lowery JC, et al.Prospective analysis of long-term psychosocial outcomes in breast reconstruction: two-year postoperative results from the Michigan Breast Reconstruction Outcomes Study[J]. Ann Surg, 2008, 247(6): 1019-1028. [23] Metcalfe KA, Semple J, Quan ML, et al.Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstruction[J]. Ann Surg Oncol, 2012, 19(1): 233-241. [24] Yurek D, Farrar W, Andersen BL.Breast cancer surgery: comparing surgical groups and determining individual differences in postoperative sexuality and body change stress[J]. J Consult Clin Psychol, 2000, 68(4): 697-709. [25] Morales L, Neven P, Timmerman D, et al.Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients[J]. Anticancer Drugs, 2004, 15(8): 753-760. [26] Albornoz CR, Matros E, McCarthy CM, et al. Implant breast reconstruction and radiation: a multicenter analysis of long-term health-related quality of life and satisfaction[J]. Ann Surg Oncol, 2014, 21(7): 2159-2164. [27] Andrade WN, Semple JL. Patient self-assessment of the cosmetic results of breast reconstruction [J]. Plast Reconstr Surg, 2006, 117(1): 44-47; discussion 48-49. [28] Dizon D S, Suzin D, McIlvenna S. Sexual health as a survivorship issue for female cancer survivors[J]. Oncologist, 2014, 19(2): 202-210. [29] Roe H.Chemotherapy-induced alopecia: advice and support for hair loss[J]. Br J Nurs, 2011, 20(10): S4-11. [30] Krychman M L, Carter J, Aghajanian C A, et al.Chemotherapy-induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma[J]. Gynecol Oncol, 2004, 93(2): 561-563. [31] Biglia N, Moggio G, Peano E, et al.Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight[J]. J Sex Med, 2010, 7(5): 1891-1900. [32] Hwang SY, Chang SJ, Park BW.Does chemotherapy really affect the quality of life of women with breast cancer?[J]. J Breast Cancer, 2013, 16(2): 229-235. [33] Pagani O, Regan MM, Walley BA, et al.Adjuvant exemestane with ovarian suppression in premenopausal breast cancer[J]. N Engl J Med, 2014, 371(2): 107-118. [34] Baumgart J, Nilsson K, Evers AS, et al.Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer[J]. Menopause, 2013, 20(2): 162-168. [35] Schover LR, Baum GP, Fuson LA, et al.Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors[J]. J Sex Med, 2014, 11(12): 3102-3111. [36] 郭欣然,王鑫鑫,张琬,等. 青年乳腺癌生存者性生活质量的干预研究进展[J]. 全科护理, 2020, 18(29): 3920-3923. [37] Lopresti M, Rizack T, Dizon DS.Sexuality, fertility and pregnancy following breast cancer treatment[J]. Gland Surg, 2018, 7(4): 404-410. [38] Loprinzi CL, Abu-Ghazaleh S, Sloan JA, et al.Phase Ⅲ randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer[J]. J Clin Oncol, 1997, 15(3): 969-973. [39] Yodplob T, Sirisopana K, Jongwannasiri M, et al.Local treatment with a polycarbophil-based cream in postmenopausal women with genitourinary syndrome of menopause[J]. Int Urogynecol J, 2021, 32(2): 317-322. [40] Barton DL, Shuster LT, Dockter T, et al.Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)[J]. Support Care Cancer, 2018, 26(4): 1335-1343. [41] Melisko ME, Goldman ME, Hwang J, et al.Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial[J]. JAMA Oncol, 2017, 3(3): 313-319. [42] Goetsch MF, Lim JY, Caughey AB.A Practical Solution for Dyspareunia in Breast Cancer Survivors: A Randomized Controlled Trial[J]. J Clin Oncol, 2015, 33(30): 3394-3400. [43] Marsh S, Borges VF, Coons HL, et al.Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers[J]. Breast Cancer Res Treat,2020, 184(3): 655-663. [44] Hummel SB, van Lankveld J, Oldenburg HSA, et al. Internet-Based Cognitive Behavioral Therapy Realizes Long-Term Improvement in the Sexual Functioning and Body Image of Breast Cancer Survivors[J]. J Sex Marital Ther, 2018, 44(5): 485-496. [45] Fatehi S, Maasoumi R, Atashsokhan G, et al.The effects of psychosexual counseling on sexual quality of life and function in Iranian breast cancer survivors: a randomized controlled trial[J]. Breast Cancer Res Treat,2019, 175(1): 171-179. [46] Goldfinger C, Pukall CF, Gentilcore-Saulnier E, et al.A prospective study of pelvic floor physical therapy: pain and psychosexual outcomes in provoked vestibulodynia[J]. J Sex Med, 2009, 6(7): 1955-1968. [47] 付伟,李萍,钟银燕. 延续性护理研究综述[J].中国实用护理杂志, 2010, 26(4): 27-30. [48] Fergus KD, McLeod D, Carter W, et al. Development and pilot testing of an online intervention to support young couples′ coping and adjustment to breast cancer[J]. Eur J Cancer Care (Engl), 2014, 23(4): 481-492. |
| [1] | WU Hui-qian, NI Heng-li, ZHOU Ai-jun, YUAN Hang, LI Jian-ming. Tumor infiltrating lymphocytes predict the efficacy of neoadjuvant chemotherapy for breast cancer [J]. Lingnan Modern Clinics In Surgery, 2024, 24(02): 100-105. |
| [2] | DONG Yi-ming, SHI Chuan-ping, LIAO Jian-you. Effects of knockdown BRIX1 on proliferation, migration and invasion of triple negative breast cancer cells [J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 42-48. |
| [3] | WU Wen-xia, ZHANG Meng. The effect of metabolic syndrome on prognosis of non-triple negative breast cancer [J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 49-53. |
| [4] | YAN Shan-shan, LEI Wen, LI Shuai-jie, WANG Yong-nan. Prognostic value of HIST1H4F gene methylation in triple-negative breast cancer [J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 54-58. |
| [5] | MENG Lan-lan, JIN Hao, YAO Yan-dan. Predictive value of tumor infiltrating lymphocytes in breast cancer patients under different molecular subtypes [J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 76-86. |
| [6] | WAN Jian, LIU Meng-yao, LI Shuai-jie, LIU Yi-ting, LAO Xiao-xia, CHEN Yong. Observation of bone marrow suppression and adverse reactions after chemotherapy after breast cancer surgery [J]. Lingnan Modern Clinics In Surgery, 2023, 23(06): 473-479. |
| [7] | LIU Zi-fei, HUANG Peng-han, JIANG Yong-xue, ZENG Wen-feng. Single-cell profiling reveals that chemotherapy potentiates antitumor immunity in breast cancer through spermidine metabolism modulation [J]. Lingnan Modern Clinics In Surgery, 2023, 23(05): 379-386. |
| [8] | WU Xiao-yong, YAN Xue-min, ZHANG Jia-yi, WEN Jin-xu, ZHU Jia, WANG Yue-xin. Adenoid cystic carcinoma of breast: two cases and review of literature [J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 343-346. |
| [9] | JIN Xiao-yan, LIU Shu-qiong, LUO Shu-juan. Discussion on general practice management model of breast cancer [J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 238-241. |
| [10] | YAO Xin-yi, XU Bao-hong, ZHANG Meng-ting, HUANG Yong-xin. Functional and mechanistic study of FOXA1 in promoting the proliferation of breast cancer by regulating the transcription of XBP1 [J]. Lingnan Modern Clinics In Surgery, 2023, 23(01): 10-18. |
| [11] | SHEN Mei-ying, PAN Hua-wen, ZHAO Li, HU Bo-tao, XU Bo, WEI Wei, CUI Jun-wei. The expression and clinical significance of aldehyde dehydrogenase 1 in sentinel lymph nodes of breast cancer [J]. Lingnan Modern Clinics In Surgery, 2023, 23(01): 19-25. |
| [12] | YAO Gong-zhi, JIANG Hui-yue, LIN Jia-li, SUN Lu. Application of pure wave linear array probe in the diagnosis of early breast cancer and the localization of tumor margin before breast conserving resection [J]. Lingnan Modern Clinics In Surgery, 2022, 22(06): 542-546. |
| [13] | WANG Yong-nan, YAN shan-shan. A case of breast cancer with nipple hemorrhage as the only clinical manifestation [J]. Lingnan Modern Clinics In Surgery, 2022, 22(06): 592-594. |
| [14] | CHEN Wan-na, LIANG Xiao-li, ZHANG Zhan-qiang, XU He-yang, LIN Bo, ZHANG Zhao-xi, YU Ju, ZHENG Liang, HUANG Jin-yao, ZHANG Jing, LU Yi-lin, HUANG Jia-yong, LI Rui-xia, LI Jie, LV Wei-ming. Cost-effectiveness and Qol of PEGrhGCSF prophylaxis for breast cancer patients receiving adjuvant chemotherapy [J]. Lingnan Modern Clinics In Surgery, 2022, 22(05): 451-457. |
| [15] | CHEN Jing-Sen, ZHANG Wen-Xia, LI Huan, XIONG Zhi-yi, WANG En-li. The clinical research of all-digital mammography improve the detection rate of simultaneity of bilateral breast cancer [J]. Lingnan Modern Clinics In Surgery, 2022, 22(03): 223-226. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||